Citadel Advisors’s LumiraDx Limited Common Shares LMDX Stock Holding History

Citadel Advisors’s Portfolio LMDX Stock Details LMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,322	Closed	-$16K	–	15541
2023 Q1	$16K	Buy	+34,322	New	+$32.9K	﹤0.01%	13230
2022 Q4	–	Sell	-38,718	Closed	-$39K	–	15676
2022 Q3	$39K	Buy	+38,718	New	+$64.2K	﹤0.01%	11777
2022 Q2	–	Sell	-14,631	Closed	-$88K	–	14481
2022 Q1	$88K	Sell	14,631 -17,024	-54%	-$138K	﹤0.01%	12402
2021 Q4	$281K	Sell	31,655 -6,658	-17%	-$59.3K	﹤0.01%	11060
2021 Q3	$317K	Buy	+38,313	New	+$311K	﹤0.01%	10954

Other funds holding LMDX

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

BWA

BDO Wealth Advisors Jacksonville, Florida $872M AUM 15.17% 1-Year Est. Return

CAG

Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return

Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Citadel Advisors's LMDX Position: Q2 2023 in Review

Citadel Advisors sold out of LumiraDx Limited Common Shares (LMDX) in Q2 2023, closing a stake of 34,322 shares — an estimated $16K sold.

Citadel Advisors first reported a position in LMDX in Q3 2021 and held it in 5 quarters. The position peaked at $317K in Q3 2021. 35 funds tracked by Wall St. Rank hold LMDX as of Q2 2023.

Citadel Advisors reported no remaining LumiraDx Limited Common Shares position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 34,322 LumiraDx Limited Common Shares shares in Q2 2023, an estimated $16K.
Citadel Advisors first reported a position in LumiraDx Limited Common Shares in Q3 2021 and held it in 5 quarters.
Citadel Advisors's LumiraDx Limited Common Shares position peaked at $317K in Q3 2021.
35 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.